(AIMT) |
| 0 (0%) 01-14 06:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 40.40 |
| Resistance 1: | 34.59 |
| Pivot price: | 34.41 |
| Support 1: | 34.33 |
| Support 2: | 34.17 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 29 Dec 2025
PW GATE REAL Test 2026 Offers Real CBT Exam Experience - Physics Wallah
Fri, 30 Jun 2023
Abdominal Inflammatory Myofibroblastic Tumour Presenting as a Pancreatic Mass: A Case Report - Cureus
Mon, 17 Apr 2023
Meet Don Jones - CanvasRebel Magazine
Sat, 05 Sep 2020
Kaskela Law LLC Announces Stockholder Investigation of Aimmune Therapeutics, Inc. (AIMT) and Encourages Investors to Contact the Firm - Chartmill
Mon, 31 Aug 2020
Nestlé to acquire Aimmune Therapeutics - GlobeNewswire
Mon, 31 Aug 2020
Nestlé to acquire peanut allergy drugmaker for $2.6B - drugdiscoverytrends.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
